Concepedia

Katherine Lazarides

KL

Statistics

Publications

12

Citations

1.5K

H-Index

11

Active since

2006

Affiliations

Molecular Oncology (United States)(Current)

Tufts Medical Center

Tufts University

Deciphera Pharmaceuticals (United States)

Harvard University

Katherine Lazarides is an author at Molecular Oncology (United States) specializing in medicine, molecular oncology, and bcr-abl1 fusion gene.

Publications per year

2006–2022

12

Publications

12

Requirement for CD44 in homing and engraftment of BCR-ABL–expressing leukemic stem cells

Daniela S. Krause, Katherine Lazarides, Ulrich H. von Andrian et al. · Nature Medicine · 2006 · 403 citations

Medicine, Hematology, Oncology +14

Molecular Pathogenesis and Therapy of Polycythemia Induced in Mice by JAK2 V617F

Virginia M. Zaleskas, Daniela S. Krause, Katherine Lazarides et al. · PLoS ONE · 2006 · 215 citations · Full text

Medicine, Hematology, Pathobiology +15

Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036

Wayne W. Chan, Scott Wise, Michael D. Kaufman et al. · Cancer Cell · 2011 · 207 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2V617F in mice

Christoph Walz, Wesam Ahmed, Katherine Lazarides et al. · Blood · 2012 · 158 citations · Full text

Medicine, Hematology, Immunology +11

Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins

Leila M. Sevigny, Ping Zhang, Andrew Bohm et al. · Proceedings of the National Academy of Sciences · 2011 · 119 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 12